**Metropolis Healthcare’s Micro-Marketing Strategy Aims for 2% Revenue Growth**
Metropolis Healthcare is implementing targeted micro-marketing strategies to enhance its presence in key regions, with the expectation of achieving an additional 2% revenue growth in the upcoming quarter. CEO Surendran Chemmenkotil shared insights on this approach, which involves segmenting the country into over 100 micro-markets that exhibit similar competitive dynamics, growth potential, and opportunities.
The company is adapting its services by introducing region-specific pricing, modifying its partner and distribution models to meet local demands, and customizing test offerings based on prevalent disease patterns. Given that diagnostics is inherently a hyper-regional business, this strategy is anticipated to strengthen Metropolis’s foothold in critical markets.
Chemmenkotil emphasized that this micro-marketing approach will define the company’s operational strategy moving forward. Traditionally, diagnostic firms have maintained uniform pricing across India, often overlooking regional variations. However, Metropolis plans to adjust its pricing based on patient needs and market data, allowing for potential price increases in certain tests and packages where opportunities arise.
In terms of expansion, Metropolis Healthcare aims to grow its network by adding 90 laboratories and 2,000 service centers by FY25. Chemmenkotil confirmed that the company is on track, having already established around 25 labs and 500 centers this fiscal year, increasing its reach from 300 to approximately 700 towns. The focus is primarily on tier 2 and tier 3 cities, with plans to extend to 1,000 towns by the end of the next fiscal year.
To enhance its regional expansion, Metropolis Healthcare, under the guidance of CEO Chemmenkotil, is focusing on micro markets. The company has divided the country into more than 100 micro-markets with similar competitive dynamics, growth potential, and opportunities. Through this segmentation, Metropolis Healthcare aims to introduce region-specific pricing and modify its partner and distribution models to meet the specific demands of each micro-market. Additionally, the company is customizing its test offerings to cater to the unique needs of these micro-markets. Looking forward, Metropolis Healthcare expects future growth to be primarily inorganic, as it establishes a strong presence in its core markets. The impact of the newly established labs on overall performance will be evaluated within 12 to 18 months. The company has divided the country into more than 100 micro-markets with similar competitive dynamics, growth potential, and opportunities. Through this segmentation, Metropolis Healthcare aims to introduce region-specific pricing and modify its partner and distribution models to meet the specific demands of each micro-market. Additionally, the company is customizing its test offerings to cater to the unique needs of these micro-markets. Looking forward, Metropolis Healthcare expects future growth to be primarily inorganic, as it establishes a strong presence in its core markets. The impact of the newly established labs on overall performance will be evaluated within 12 to 18 months.